Cardio Diagnostics (NASDAQ:CDIO – Get Free Report) is expected to announce its earnings results before the market opens on Monday, August 11th. Analysts expect the company to announce earnings of ($1.80) per share and revenue of $0.08 million for the quarter.
Cardio Diagnostics (NASDAQ:CDIO – Get Free Report) last announced its quarterly earnings results on Thursday, May 15th. The company reported ($0.97) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.91). The firm had revenue of $0.00 million for the quarter, compared to analysts’ expectations of $0.05 million. Cardio Diagnostics had a negative net margin of 28,539.39% and a negative return on equity of 84.55%.
Cardio Diagnostics Price Performance
Shares of CDIO opened at $3.45 on Friday. The firm has a fifty day simple moving average of $4.08 and a two-hundred day simple moving average of $9.11. Cardio Diagnostics has a twelve month low of $3.22 and a twelve month high of $53.10.
Cardio Diagnostics Company Profile
Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.
Featured Stories
- Five stocks we like better than Cardio Diagnostics
- 3 Fintech Stocks With Good 2021 Prospects
- Airbnb Beats Earnings, But the Growth Story Is Losing Altitude
- What Are Dividends? Buy the Best Dividend Stocks
- Netflix Bulls vs. Bears: Who Wins This Pullback?
- Stock Dividend Cuts Happen Are You Ready?
- Viasat: Why a Wall of Cash Has Shorts Running for Cover
Receive News & Ratings for Cardio Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardio Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
